The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aratana Therapeutics Inc. Common 03874P101 9,457 1,117,875 SH   SOLE   1,117,875 0 0
Chiasma, Inc. Common 16706W102 112,949 5,681,544 SH   SOLE   5,681,544 0 0
CoLucid Pharmaceuticals, Inc. Common 19716T101 84 21,806 SH   SOLE   21,806 0 0
Conatus Pharmaceuticals, Inc. Common 20600T108 5,305 1,192,080 SH   SOLE   1,192,080 0 0
EnteroMedics, Inc. Common 29365M208 289 1,113,168 SH   SOLE   1,113,168 0 0
EpiZyme, Inc. Common 29428V104 22,244 1,729,674 SH   SOLE   1,729,674 0 0
MacroGenics, Inc. Common 556099109 68 3,168 SH   SOLE   3,168 0 0
Mast Therapeutics, Inc. Common 576314108 1,480 2,551,851 SH   SOLE   2,551,851 0 0
Nevro Corporation Common 64157F103 9,829 211,884 SH   SOLE   211,884 0 0
PharmAthene, Inc. Common 71714G102 8,442 6,347,614 SH   SOLE   6,347,614 0 0
Portola Pharmaceuticals, Inc. Common 737010108 52,025 1,220,672 SH   SOLE   1,220,672 0 0
Proteon Therapeutics, Inc. Common 74371L109 13,679 983,381 SH   SOLE   983,381 0 0
Radius Health, Inc. Common 750469207 404,164 5,831,253 SH   SOLE   5,831,253 0 0
Sangamo Biosciences, Inc. Common 800677106 127 22,487 SH   SOLE   22,487 0 0
Trivascular Technologies, Inc. Common 89685A102 8,883 1,776,692 SH   SOLE   1,776,692 0 0
Verastem, Inc. Common 92337C104 1,025 572,874 SH   SOLE   572,874 0 0